Source - RNS
RNS Number : 4040X
ProPhotonix Limited
10 August 2018

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.



August 10, 2018                       

ProPhotonix Limited

("ProPhotonix" or the "Company")

Trading update and De-restriction of Restricted Stock Line

ProPhotonix Limited (London Stock Exchange - AIM: PPIX and PPIR, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, today announces a trading update for the six months ended June 30, 2018 (H1-2018) and pending move of restricted shares (PPIR) to free-trading unrestricted shares (STKR/PPIX).

Trading Update 

Revenue for H1-2018 is expected to be approximately $8.8 million, an increase of 4% over the 2017 comparable figure (H1-2017: $8.5 million). Increased revenue was generated from higher sales to several major customers, although this was less than internal Company expectations.  These gains were partly offset by a decrease in sales from one large customer that converted to an alternate technology in the second quarter of 2017 (as previously announced on July 14, 2017).  Finally, the first half revenue was impacted by delayed shipments of products valued at approximately $0.5 million that had been expected to be recognized in H1-2018 but will instead be recognized in H2-2018. 

A competitive market environment, revenue mix and higher component costs have contributed to gross profit margins declining to approximately 39% in H1-2018 (H1-2017: 44%). Higher SG&A expenses, mainly in respect of stock based compensation expense, have adversely  impacted the operating and net income for H1-2018 as compared to H1-2017.  Operating loss (unaudited) for H1-2018 is expected to be approximately $0.5million (H1-2017: $0.6 million profit).  

Earnings before interest, taxes, depreciation, amortization, and stock-based compensation (adjusted EBITDA) for H1-2018 are expected to be approximately $0.2 million (unaudited), compared to $0.7 million in H1-2017 due to the matters set out above. 


The order book as of June 30, 2018 is $7.3 million (2017: $6.0 million) and was $7.3 million as of December 31, 2017.  The Board currently expects full year 2018 revenue of approximately $19.0 million, gross profit margin at approximately 41%, adjusted EBITDA of between $1.25 and $1.50 million, and net income of break-even. 

The Company's unaudited interim results for the six months to June 30, 2018 will be released in early September 2018. 

De-restriction of Restricted Stock Line 

As a company domiciled in the US, ProPhotonix is subject to the Securities Act of 1933, the Securities Exchange Act of 1934 and the jurisdiction and rules of the US Securities Exchange Commission ("SEC"). Among those rules is Regulation S which requires the Company, as a US issuer, to issue shares that bear restrictive legends for a 12 month period. The 22,042,143 ProPhotonix restricted common shares of $0.001 each  trade under the ISIN USU743121142 and with the ticker AIM:PPIR ("Restricted Shares").  

The Restricted Shares which were issued to trading on AIM on August 21, 2017 are eligible for transfer on September 1, 2018 to the unrestricted line (ISIN: US7434651060, tickers OTC:STKR and AIM:PPIX). Shareholders who wish to transfer their Restricted Shares should contact the Company or Computershare for further instructions.

Tim Losik, CEO, Commented:


"We remain very optimistic about 2019 and beyond.  Whilst revenue recognized has been slower than expected in this first half of 2018, our opportunity pipeline for laser and LED OEM products and UV LED product sales is stronger than at any time.  Also, during the first half of 2018 we secured our sixth development project with a Fortune 50 original equipment manufacturer ("OEM"), and signed a large engineering design project, valued in excess of $0.4 million, which will be delivered between Q4 2018 and Q2 2019, with production expected thereafter.  We continue to invest in production capacity and technical capability as we take on additional new customers and OEM products.  These investments will occur in advance of realized revenue to complete the production build out necessary for the UV LED products."



ProPhotonix Limited                                                       Tel: +1 603 893 8778

Tim Losik, President and CEO                                        [email protected]


Cantor Fitzgerald Europe                                                Tel: +44 (0)207 894 7000

(Nominated Adviser and Broker)

Richard Salmond          

David Foreman  


About ProPhotonix

ProPhotonix  Limited,  headquartered  in  Salem,  New  Hampshire,  is  a  high  technology  designer  and  manufacturer  of LED  illumination  systems  and  laser  diode  modules  for   industry   leading  OEMs  and  medical  equipment  companies.  In  addition,  the  Company  distributes  premium  diodes  for  Ushio,  Osram,  QSI,  Panasonic,  and  Sony.  The  Company  serves  a  wide  range  of  markets  including  the  machine  vision,  industrial  inspection,  security,  and  medical  markets.  ProPhotonix  has  offices  and  subsidiaries  in  the  U.S.,  Ireland,  U.K.,  and  Europe.  For  more  information  about  ProPhotonix  and  its  innovative  products,  visit  the  Company's  web  site  at

Cautionary Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow ProPhotonix to meet all of its business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit